Ledger S - Search Results

1

Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2.

Bowden-Reid E, Ledger S, Zhang Y, Di Giallonardo F, Aggarwal A, Stella AO, Akerman A, Milogiannakis V, Walker G, Rawlinson W, Turville S, Kelleher AD, Ahlenstiel C. Bowden-Reid E, et al. Among authors: ledger s. Antiviral Res. 2023 Sep;217:105677. doi: 10.1016/j.antiviral.2023.105677. Epub 2023 Jul 20. Antiviral Res. 2023. PMID: 37478918 Free article.

2

Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46.

Ledger S, Howe A, Turville S, Aggarwal A, Savkovic B, Ong A, Wolstein O, Boyd M, Millington M, Gorry PR, Murray JM, Symonds G. Ledger S, et al. J Gene Med. 2018 Feb;20(2-3):e3006. doi: 10.1002/jgm.3006. J Gene Med. 2018. PMID: 29552747

3

RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.

Méndez C, Ledger S, Petoumenos K, Ahlenstiel C, Kelleher AD. Méndez C, et al. Among authors: ledger s. Retrovirology. 2018 Oct 4;15(1):67. doi: 10.1186/s12977-018-0451-0. Retrovirology. 2018. PMID: 30286764 Free PMC article.

4

Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.

Zhang Y, Almazi JG, Ong HX, Johansen MD, Ledger S, Traini D, Hansbro PM, Kelleher AD, Ahlenstiel CL. Zhang Y, et al. Among authors: ledger s. Int J Mol Sci. 2022 Feb 22;23(5):2408. doi: 10.3390/ijms23052408. Int J Mol Sci. 2022. PMID: 35269550 Free PMC article. Review.

5

Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection.

Agbosu EE, Ledger S, Kelleher AD, Wen J, Ahlenstiel CL. Agbosu EE, et al. Among authors: ledger s. Pharmaceutics. 2022 Jun 26;14(7):1352. doi: 10.3390/pharmaceutics14071352. Pharmaceutics. 2022. PMID: 35890248 Free PMC article. Review.

6

Advances in HIV Gene Therapy.

Kitawi R, Ledger S, Kelleher AD, Ahlenstiel CL. Kitawi R, et al. Among authors: ledger s. Int J Mol Sci. 2024 Feb 28;25(5):2771. doi: 10.3390/ijms25052771. Int J Mol Sci. 2024. PMID: 38474018 Free PMC article. Review.

7

Current State of Therapeutics for HTLV-1.

Wang TT, Hirons A, Doerflinger M, Morris KV, Ledger S, Purcell DFJ, Kelleher AD, Ahlenstiel CL. Wang TT, et al. Among authors: ledger s. Viruses. 2024 Oct 15;16(10):1616. doi: 10.3390/v16101616. Viruses. 2024. PMID: 39459949 Free PMC article. Review.

8

A quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells.

Savkovic B, Nichols J, Birkett D, Applegate T, Ledger S, Symonds G, Murray JM. Savkovic B, et al. Among authors: ledger s. PLoS Comput Biol. 2014 Jun 19;10(6):e1003681. doi: 10.1371/journal.pcbi.1003681. eCollection 2014 Jun. PLoS Comput Biol. 2014. PMID: 24945407 Free PMC article.

9

CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.

Hütter G, Bodor J, Ledger S, Boyd M, Millington M, Tsie M, Symonds G. Hütter G, et al. Among authors: ledger s. Viruses. 2015 Jul 27;7(8):4186-203. doi: 10.3390/v7082816. Viruses. 2015. PMID: 26225991 Free PMC article. Review.

10

The utility of the Living Planet Index as a policy tool and for measuring nature recovery.

McRae L, Cornford R, Marconi V, Puleston H, Ledger SEH, Deinet S, Oppenheimer P, Hoffmann M, Freeman R. McRae L, et al. Among authors: ledger seh. Philos Trans R Soc Lond B Biol Sci. 2025 Jan 9;380(1917):20230207. doi: 10.1098/rstb.2023.0207. Epub 2025 Jan 9. Philos Trans R Soc Lond B Biol Sci. 2025. PMID: 39780599 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters